MIAMI, Oct. 5, 2015— Global Stem Cells Group, Inc. has named Stemlab.com founder and prominent plastic surgeon Alfredo Hoyos, M.D. as permanent head of the GSCG Faculty. Hoyos has been an active member of the GSCG team since signing on as an exclusive representative for the stem cell leader’s Colombian territory in September, 2014.
The Global Stem Cells Group / Stem Cell Training Faculty consists of a distinguished board of physicians, all experts in stem cell and regenerative medicine. The faculty reviews, updates and makes decision pertaining to the training programs offered through the Stem Cell Training division of Global Stem Cells Group. Faculty members also share the latest hand-on techniques and technologies with physicians, nurses, and other health care professionals through SCT’s instructional stem cell training courses.
Hoyos divides his time between practices in Miami and Bogota, Colombia.
Hoyos earned his medical degree at the University of Rosario and completed his residency in plastic surgery at Rosario – Saint Joseph Hospital in Bogotá, Colombia. He later founded Stemlab to further the development of aesthetic techniques using stem cell (stromal) derived from adipose tissue.
Stemlab is currently conducting extensive research in regenerative medicine in an effort to establish stem cell treatments that can repair damaged tissue in living organisms, using natural biological mechanisms that are proving useful in auto repair processes on damaged tissue.
Hoyos is the inventor of the High Definition Liposculpture (HDL) and Dynamic Definition at Lipoplasty (4D) techniques as well as other advanced techniques that focus on body contouring.
Author of several scientific articles that discuss innovations and new technologies that work on body contour, Hoyos is also the inventor of proprietary tools and applications of plastic surgery devices.
To learn more, visit the Global Stem Cells Group website, email bnovas@steemcellsgroup.com, or call 
+1 305 560 5337.
About the Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
